Genomic Valley Biotech Ltd share price logo

Genomic Valley Biotech Ltd

BSE: 539206

Small Cap

₹29.88

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Genomic Valley Biotech Stock Performance

as on September 3, 2026 at 7:46 pm IST

  • ₹29.88
    ₹29.88

  • 52 Week's Low

    52 Week's High

    ₹20.10
    ₹41.95
    downward going graph

    32.73%

    Downside

    40.39%

    Upside

    downward going graph

Genomic Valley Biotech share price movements today

Previous Close
₹29.88
Open
₹29.88
Volume
100.00
Upper Circuit
₹31.37
Lower Circuit
₹28.39
Day's Low - High
₹29.88 - ₹29.88
52 Week Low - High
₹20.10 - ₹41.95

Genomic Valley Biotech Historical Returns

1 Month Return
+ 6.71 %
3 Month Return
+ 12.58 %
1 Year Return
-26.98 %
3 Year Return
+ 29.91 %
5 Year Return
+ 32.8 %

Genomic Valley Biotech Fundamentals

as on September 3, 2026 at 2:16 pm IST

Market Cap

₹9.13 Cr

Return on Equity (ROE)

9.69

PE Ratio (TTM)

0

Return on capital employed (ROCE)

12.11

Industry PE ratio

-

Beta (LTM)

0.33

P/B Ratio

4.59

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

-50

EPS (TTM)

0

Book Value

0

Genomic Valley Biotech Technical Analysis

Track how Genomic Valley Biotech technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish4
Bullish2
Neutral9

Oscillators

Name

Value

Action

MACD level (12,26)
0
Bearish
CCI (20)
-66.67
Neutral
RSI (14)
99.99
Bearish
Momentum (10)
0
Neutral
ADI (14)
99.97
Neutral
Ultimate Oscillator (7,14,28)
0
Bearish

Moving Averages

Name

Value

Action

SMA (20)
29.88
Neutral
EMA (20)
29.88
Neutral
VWMA (20)
29.88
Neutral
SMA (50)
29.88
Neutral
EMA (50)
29.88
Bullish
SMA (200)
29.88
Neutral
EMA (200)
29.65
Bullish
KAMA (200)
29.88
Neutral
DEMA (200)
30.08
Bearish

Genomic Valley Biotech Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Genomic Valley Biotech with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Genomic Valley Biotech Ltd image
Genomic Valley Biotech Ltd
NA9.136.56%0.00-12
BIL Vyapar Ltd image
BIL Vyapar Ltd
NA12.23-13.16%-6.2861
NMS Global Ltd image
NMS Global Ltd
NA11.695.35%0.97NA18
NBCC (India) Ltd image
NBCC (India) Ltd
BUY22,950.0036.8%0.0055712,038
Shree Rama Newsprint Ltd image
Shree Rama Newsprint Ltd
NA460.2711.84%0.00-10744
See all

Genomic Valley Biotech Stock’s Investor Sentiment and Interest

Search interest for Genomic Valley Biotech Ltd Stock has increased by 62% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:62% versus previous 30 day period

Genomic Valley Biotech Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
0.07
0.04
-
0.16
0.21
0.22
0.26
0.09
0.09
0.05
0.04
0.04
Other Income
-
-
-
-
0.01
-
-
-
-
-
-
-
Total Income
0.07
0.04
-
0.16
0.21
0.22
0.26
0.09
0.09
0.05
0.04
0.04
Expenses
0.04
0.02
0.04
0.03
0.06
0.06
0.26
0.06
0.09
0.04
0.03
0.02
Operating Profit
0.03
0.02
-0.04
0.13
0.15
0.16
-
0.03
-
0.01
0.01
0.02
Operating Profit Margin %
42.86%
50%
0%
81.25%
71.43%
72.73%
0%
33.33%
0%
20%
25%
50%
Profit Before Interest, Tax and Depreciation
0.02
0.02
-0.04
0.13
0.15
0.16
-
0.03
-
0.01
-
0.02
Profit Before Tax
0.02
0.02
-0.04
0.13
0.15
0.16
-
0.03
-
0.01
-
0.02
Tax Paid
-
-
-
-
-
-
0.09
-
-
-
0.01
-
Profit After Tax
0.02
0.02
-0.04
0.13
0.15
0.16
-0.08
0.02
-
0.01
-0.01
0.01
Total Net profit including share of profit / Loss from associate company
0.02
0.02
-0.04
0.13
0.15
0.16
-0.08
0.02
-
0.01
-0.01
0.01
EPS
0.08
0.07
-0.15
0.42
0.48
0.51
-0.27
0.08
0.01
0.03
-0.03
0.05
Actual EPS
0.08
0.07
-0.15
0.42
0.48
0.51
-0.27
0.08
0.01
0.03
-0.03
0.05
Adjusted EPS
0.08
0.07
-0.15
0.42
0.48
0.51
-0.27
0.08
0.01
0.03
-0.03
0.05
Diluted EPS
0.08
0.07
-0.15
0.42
0.48
0.51
-0.27
0.08
0.01
0.03
-0.03
0.05

Genomic Valley Biotech Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
0.59
0.99
0.85
0.21
0.07
2.72
0.17
0.84
0.27
Other Income
0.03
0.01
0.01
-
0.5
0.04
-
-
-
Total Income
0.63
1
0.86
0.21
0.57
2.77
0.17
0.85
0.27
Expenses
0.49
0.57
0.3
0.35
0.45
2.11
0.15
0.4
0.22
Operating Profit
0.1
0.42
0.55
-0.14
-0.38
0.61
0.02
0.44
0.05
Operating Profit Margin %
16.95%
42.42%
64.71%
-66.67%
-542.86%
22.43%
11.76%
52.38%
18.52%
Profit Before Interest, Tax and Depreciation
0.13
0.43
0.56
-0.14
0.13
0.66
0.02
0.44
0.04
Interest
-
-
0.18
0.18
0.04
-
-
-
-
Depreciation
0.08
0.19
0.18
0.19
0.08
0.01
-
-
-
Profit Before Tax
0.05
0.24
0.2
-0.51
0.01
0.65
0.02
0.44
0.04
Tax Paid
0.02
-
-0.08
0.06
0.01
-
-
0.09
0.01
Profit After Tax
0.03
0.23
0.29
-0.56
-0.01
0.65
0.02
0.36
0.03
Total Net profit including share of profit / Loss from associate company
0.03
0.23
0.29
-0.56
-0.01
0.65
0.02
0.36
0.03
EPS
0.11
0.76
0.94
-1.83
-0.03
2.12
0.05
1.17
0.1
Actual EPS
0.11
0.76
0.94
-1.83
-0.03
2.12
0.05
1.17
0.1
Adjusted EPS
0.11
0.76
0.94
-1.83
-0.03
2.12
0.05
1.17
0.1
Diluted EPS
0.11
0.76
0.94
-1.83
-0.03
2.12
0.05
1.17
0.1

Genomic Valley Biotech Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
-0.69
0.35
0.87
-1.04
0.44
1.48
-2.13
-0.78
-0.02
0.03
Cash Flow from Investing Activities
0.52
-0.32
-0.91
0.37
-0.48
-1.58
3.67
1.52
-0.02
0.01
Cash Flow from Financing Activities
-
-
-
0.73
-
0.07
-1.55
-0.7
-
-
Net Cash Flow
-0.16
0.04
-0.04
0.06
-0.04
-0.03
-0.01
0.04
-0.04
0.04

Genomic Valley Biotech Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
65.04%
64.2%
64.14%
54.67%
46.83%
46.78%
46.72%
46.72%
46.06%
46.06%
46.06%
Public
34.96%
35.8%
35.86%
45.33%
53.17%
53.22%
53.28%
53.28%
53.94%
53.94%
53.94%
Total Outstanding Shares
30,54,500
30,54,500
30,54,500
30,54,500
30,54,500
30,54,500
30,54,500
30,54,500
30,54,500
30,54,500
30,54,500
Total Shareholders
1,014
1,334
1,540
2,128
2,497
2,504
2,460
2,459
2,522
2,481
2,448

Genomic Valley Biotech Corporate Actions

View detailed summary of the earnings and dividend history of Genomic Valley Biotech.

  • Genomic Valley Biotech Ltd Earnings Results

    Genomic Valley Biotech Ltd’s net profit fell -50% since last year same period to ₹0.01Cr in the Q1 2026-2027. On a quarterly growth basis, Genomic Valley Biotech Ltd has generated 200% jump in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Genomic Valley Biotech Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, Genomic Valley stock has moved up by 3.5%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 46.06% of holdings in Jun 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Avanti Feeds Ltd has given 19.4% return, outperforming this stock by 46.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Avanti Feeds Ltd has given 83.7% return, outperforming this stock by 53.8%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 53.94% of holdings in Jun 2026 quarter

About Genomic Valley Biotech Ltd

Genomic Valley Biotech Ltd was founded in 1994 with the aim to conduct research and production of plant tissue cultured plants, as well as to perform high-tech greenhouse and environmentally controlled poly-house production of multiple crop species. The company has developed a cluster of 300 marginal farmers to form a Farmers Producer Company, and a training centre for local ladies to develop kitchen gardens and small farms to generate income. Genomic Valley also provides turn-key cultivation projects on client's land, as well as agri-farming consultancy on a case-by-case basis. The company has a commercial plant tissue culture laboratory with an annual production capacity of 3 million plants. In this way, Genomic Valley is helping HNI clients to boost their agri-farming business by providing solutions tailored to their individual needs.

Revenue: ₹0.04Cr as on June 2026 (Q1 FY27)
Net Profit: ₹0.01Cr as on June 2026 (Q1 FY27)
Chairperson Name: Yogesh Agrawal
OrganisationGenomic Valley Biotech Ltd
HeadquartersNew Delhi
IndustryMiscellaneous
CEOYogesh Agrawal
E-voting on sharesClick here to vote

FAQs

What is Genomic Valley Biotech share price today?

Genomic Valley Biotech share price today stands at ₹29.88 as on . Genomic Valley Biotech share today touched a day high of ₹29.88 and a low of ₹29.88.

What is the 52 week high and 52 week low range for Genomic Valley Biotech share?

Genomic Valley Biotech touched a 52 week high of ₹41.95 and a 52 week low of ₹20.1. Genomic Valley Biotech share price today i.e. is trending at ₹29.88, which is -28.77% down from its 52 week high and 48.66% up from its 52 week low.

What is Genomic Valley Biotech's market capitalisation today?

Genomic Valley Biotech market capitalisation is ₹9.13 Cr as on .

How to buy Genomic Valley Biotech shares?

To buy Genomic Valley Biotech shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 539206 or Genomic Valley Biotech Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Genomic Valley Biotech shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Genomic Valley Biotech trading volume today?

Genomic Valley Biotech trading volume is 100.00 as on . This means that 100.00 shares of Genomic Valley Biotech were bought and sold on the stock market during today's trading session.